SOLARA ACTIVE Q2 : Ceo Says Ibuprofen is turning around.

Revenue grew 21% over last year and 18% over last quarter, and the business is now close to breakeven, from a loss margin of 21% just two quarters ago. As a result, overall revenue grew 33% to INR 4,178 Mn and EBITDA more than doubled, up 118% to INR 769 Mn.

SOLARA ACTIVE PHA SCI LTD

← Back to feed